Symptomatic Sinus Bradycardia in a Patient with Solitary Fibrous Tumor/Hemangiopericytoma Treated with Pazopanib.

Shioyama, Wataru; Oka, Toru; Kamada, Risa; Yagi, Toshinari; Nakanishi, Katsuhiko; Nishikawa, Tatsuya; Yasui, Taku; Fujita, Masashi

Shioyama, Wataru; Oka, Toru; Kamada, Risa; Yagi, Toshinari; Nakanishi, Katsuhiko; Nishikawa, Tatsuya; Yasui, Taku; Fujita, Masashi.

Shioyama W; Department of Onco-Cardiology, Osaka International Cancer Institute, Japan.
Oka T; Department of Onco-Cardiology, Osaka International Cancer Institute, Japan.
Kamada R; Department of Onco-Cardiology, Osaka International Cancer Institute, Japan.
Yagi T; Department of Cancer Chemotherapy Center for Outpatients, Osaka International Cancer Institute, Japan.
Nakanishi K; Department of Neurosurgery, Osaka International Cancer Institute, Japan.
Nishikawa T; Department of Onco-Cardiology, Osaka International Cancer Institute, Japan.
Yasui T; Department of Onco-Cardiology, Osaka International Cancer Institute, Japan.
Fujita M; Department of Onco-Cardiology, Osaka International Cancer Institute, Japan.

Intern Med ; 60(18): 2973-2977, 2021 Sep 15.

Article en En | MEDLINE | ID: mdl-33814488

Asunto(s)

Hemangiopericitoma; Tumores Fibrosos Solitarios; Bradicardia/inducido químicamente; Bradicardia/diagnóstico; Humanos; Indazoles; Masculino; Recurrencia Local de Neoplasia; Pirimidinas; Tumores Fibrosos Solitarios/inducido químicamente; Tumores Fibrosos Solitarios/diagnóstico; Sulfonamidas

Palabras clave

adverse event; bradycardia; cardiotoxicity; pazopanib; solitary fibrous tumor/hemangiopericytoma

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tumores Fibrosos Solitarios / Hemangiopericitoma Tipo de estudio: Diagnostic_studies Límite: Humans / Male Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google